How the accelerated adoption of agile clinical trials will reshape the research landscape in 2022

Enroll patients faster, retain patients longer, and reduce patient burden with the Science 37 Operating System™.

With a Science 37 Metasite™, sponsors and CROs can add a decentralized or virtual study arm to any study to supplement brick-and-mortar site strategy — expanding the reach of clinical trials, increasing patient reach, and accelerating study timelines.

In parallel to their Phase IIb trial, a global leader in pharmaceuticals was looking to pilot the same interventional study in major depressive disorder (MDD) using a decentralized clinical trial (DCT) model to evaluate operational feasibility, data quality, enrollment speed, and retention.

Science 37 helped expand reach beyond the confines of traditional sites, reaching patients who otherwise were unable to access the trial.

Trained coordinators consult, orchestrate, and support patient and study teams by leveraging in-depth experience and standardized processes.